nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Homicidal ideation—Varenicline—nicotine dependence	0.0524	0.0672	CcSEcCtD
Boceprevir—CMA1—cardiovascular system—nicotine dependence	0.0327	0.148	CbGeAlD
Boceprevir—Mental retardation—Varenicline—nicotine dependence	0.0301	0.0386	CcSEcCtD
Boceprevir—Gingival pain—Varenicline—nicotine dependence	0.0301	0.0386	CcSEcCtD
Boceprevir—CTSL—cardiovascular system—nicotine dependence	0.0279	0.127	CbGeAlD
Boceprevir—CTSV—midbrain—nicotine dependence	0.0267	0.121	CbGeAlD
Boceprevir—CTSL—midbrain—nicotine dependence	0.0218	0.099	CbGeAlD
Boceprevir—CTSK—cardiovascular system—nicotine dependence	0.0211	0.0956	CbGeAlD
Boceprevir—CTSS—cardiovascular system—nicotine dependence	0.0184	0.0837	CbGeAlD
Boceprevir—Anger—Varenicline—nicotine dependence	0.0184	0.0236	CcSEcCtD
Boceprevir—Respiratory tract congestion—Varenicline—nicotine dependence	0.018	0.0231	CcSEcCtD
Boceprevir—Abnormal behaviour—Varenicline—nicotine dependence	0.0176	0.0226	CcSEcCtD
Boceprevir—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.0169	0.0217	CcSEcCtD
Boceprevir—CTSV—brain—nicotine dependence	0.0168	0.0762	CbGeAlD
Boceprevir—Coronary artery disease—Varenicline—nicotine dependence	0.0166	0.0213	CcSEcCtD
Boceprevir—CTSS—midbrain—nicotine dependence	0.0144	0.0654	CbGeAlD
Boceprevir—Aphthous stomatitis—Varenicline—nicotine dependence	0.014	0.018	CcSEcCtD
Boceprevir—CTSL—brain—nicotine dependence	0.0137	0.0622	CbGeAlD
Boceprevir—Sinus congestion—Varenicline—nicotine dependence	0.0132	0.0169	CcSEcCtD
Boceprevir—Night sweats—Varenicline—nicotine dependence	0.0122	0.0156	CcSEcCtD
Boceprevir—Suicide attempt—Varenicline—nicotine dependence	0.0116	0.0148	CcSEcCtD
Boceprevir—Completed suicide—Varenicline—nicotine dependence	0.0112	0.0143	CcSEcCtD
Boceprevir—Psoriasis—Varenicline—nicotine dependence	0.0105	0.0134	CcSEcCtD
Boceprevir—CTSK—brain—nicotine dependence	0.0103	0.0469	CbGeAlD
Boceprevir—Parosmia—Varenicline—nicotine dependence	0.0101	0.013	CcSEcCtD
Boceprevir—Cyst—Varenicline—nicotine dependence	0.00983	0.0126	CcSEcCtD
Boceprevir—Paranoia—Varenicline—nicotine dependence	0.00964	0.0124	CcSEcCtD
Boceprevir—Suicidal ideation—Varenicline—nicotine dependence	0.00937	0.012	CcSEcCtD
Boceprevir—CTSS—brain—nicotine dependence	0.00905	0.0411	CbGeAlD
Boceprevir—Menorrhagia—Varenicline—nicotine dependence	0.00887	0.0114	CcSEcCtD
Boceprevir—Gingivitis—Varenicline—nicotine dependence	0.00837	0.0107	CcSEcCtD
Boceprevir—Dysphonia—Varenicline—nicotine dependence	0.00798	0.0102	CcSEcCtD
Boceprevir—Endocrine disorder—Varenicline—nicotine dependence	0.00792	0.0102	CcSEcCtD
Boceprevir—Disturbance in attention—Varenicline—nicotine dependence	0.00758	0.00973	CcSEcCtD
Boceprevir—Aggression—Varenicline—nicotine dependence	0.00748	0.00959	CcSEcCtD
Boceprevir—Chest discomfort—Varenicline—nicotine dependence	0.00742	0.00952	CcSEcCtD
Boceprevir—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00727	0.00933	CcSEcCtD
Boceprevir—Lacrimation increased—Varenicline—nicotine dependence	0.00713	0.00914	CcSEcCtD
Boceprevir—Nocturia—Varenicline—nicotine dependence	0.00708	0.00908	CcSEcCtD
Boceprevir—Musculoskeletal pain—Varenicline—nicotine dependence	0.00665	0.00853	CcSEcCtD
Boceprevir—Pulmonary embolism—Varenicline—nicotine dependence	0.00657	0.00843	CcSEcCtD
Boceprevir—Influenza like illness—Varenicline—nicotine dependence	0.00638	0.00818	CcSEcCtD
Boceprevir—Salivary hypersecretion—Varenicline—nicotine dependence	0.00638	0.00818	CcSEcCtD
Boceprevir—Photophobia—Varenicline—nicotine dependence	0.00617	0.00791	CcSEcCtD
Boceprevir—Dry eye—Varenicline—nicotine dependence	0.00607	0.00778	CcSEcCtD
Boceprevir—Mouth ulceration—Varenicline—nicotine dependence	0.00594	0.00762	CcSEcCtD
Boceprevir—Mental disability—Varenicline—nicotine dependence	0.0057	0.00731	CcSEcCtD
Boceprevir—Lymphadenopathy—Varenicline—nicotine dependence	0.00559	0.00717	CcSEcCtD
Boceprevir—Sleep disorder—Varenicline—nicotine dependence	0.00551	0.00706	CcSEcCtD
Boceprevir—Diabetes mellitus—Varenicline—nicotine dependence	0.00548	0.00703	CcSEcCtD
Boceprevir—Deafness—Varenicline—nicotine dependence	0.00533	0.00684	CcSEcCtD
Boceprevir—Eczema—Varenicline—nicotine dependence	0.00531	0.00681	CcSEcCtD
Boceprevir—Eye pain—Varenicline—nicotine dependence	0.00528	0.00677	CcSEcCtD
Boceprevir—Amnesia—Varenicline—nicotine dependence	0.00508	0.00651	CcSEcCtD
Boceprevir—Atrial fibrillation—Varenicline—nicotine dependence	0.00503	0.00645	CcSEcCtD
Boceprevir—Arthritis—Varenicline—nicotine dependence	0.00491	0.00629	CcSEcCtD
Boceprevir—Lethargy—Varenicline—nicotine dependence	0.00487	0.00624	CcSEcCtD
Boceprevir—Migraine—Varenicline—nicotine dependence	0.00469	0.00602	CcSEcCtD
Boceprevir—Affect lability—Varenicline—nicotine dependence	0.00469	0.00602	CcSEcCtD
Boceprevir—Psychotic disorder—Varenicline—nicotine dependence	0.00466	0.00597	CcSEcCtD
Boceprevir—Irritability—Varenicline—nicotine dependence	0.00455	0.00584	CcSEcCtD
Boceprevir—Mood swings—Varenicline—nicotine dependence	0.00452	0.00579	CcSEcCtD
Boceprevir—Dry skin—Varenicline—nicotine dependence	0.00437	0.00561	CcSEcCtD
Boceprevir—Abdominal pain upper—Varenicline—nicotine dependence	0.00436	0.00559	CcSEcCtD
Boceprevir—Hypokalaemia—Varenicline—nicotine dependence	0.00434	0.00557	CcSEcCtD
Boceprevir—Breast disorder—Varenicline—nicotine dependence	0.00431	0.00553	CcSEcCtD
Boceprevir—Nasopharyngitis—Varenicline—nicotine dependence	0.00426	0.00547	CcSEcCtD
Boceprevir—Gastritis—Varenicline—nicotine dependence	0.00422	0.00541	CcSEcCtD
Boceprevir—Abdominal distension—Varenicline—nicotine dependence	0.00415	0.00532	CcSEcCtD
Boceprevir—Dysphagia—Varenicline—nicotine dependence	0.00412	0.00529	CcSEcCtD
Boceprevir—Bronchitis—Varenicline—nicotine dependence	0.00396	0.00508	CcSEcCtD
Boceprevir—Abdominal discomfort—Varenicline—nicotine dependence	0.00395	0.00507	CcSEcCtD
Boceprevir—Pollakiuria—Varenicline—nicotine dependence	0.00381	0.00488	CcSEcCtD
Boceprevir—Erectile dysfunction—Varenicline—nicotine dependence	0.0038	0.00487	CcSEcCtD
Boceprevir—Photosensitivity reaction—Varenicline—nicotine dependence	0.00376	0.00482	CcSEcCtD
Boceprevir—Hyperglycaemia—Varenicline—nicotine dependence	0.00372	0.00477	CcSEcCtD
Boceprevir—Infestation NOS—Varenicline—nicotine dependence	0.00367	0.00471	CcSEcCtD
Boceprevir—Infestation—Varenicline—nicotine dependence	0.00367	0.00471	CcSEcCtD
Boceprevir—Depression—Varenicline—nicotine dependence	0.00366	0.0047	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00364	0.00467	CcSEcCtD
Boceprevir—Stomatitis—Varenicline—nicotine dependence	0.00358	0.00459	CcSEcCtD
Boceprevir—Conjunctivitis—Varenicline—nicotine dependence	0.00357	0.00458	CcSEcCtD
Boceprevir—Hepatobiliary disease—Varenicline—nicotine dependence	0.00348	0.00446	CcSEcCtD
Boceprevir—Epistaxis—Varenicline—nicotine dependence	0.00347	0.00445	CcSEcCtD
Boceprevir—Sinusitis—Varenicline—nicotine dependence	0.00345	0.00442	CcSEcCtD
Boceprevir—Hypoaesthesia—Varenicline—nicotine dependence	0.00328	0.00421	CcSEcCtD
Boceprevir—Urinary tract disorder—Varenicline—nicotine dependence	0.00326	0.00418	CcSEcCtD
Boceprevir—ABCB1—cardiovascular system—nicotine dependence	0.00325	0.0148	CbGeAlD
Boceprevir—Oedema peripheral—Varenicline—nicotine dependence	0.00325	0.00417	CcSEcCtD
Boceprevir—Connective tissue disorder—Varenicline—nicotine dependence	0.00324	0.00416	CcSEcCtD
Boceprevir—Urethral disorder—Varenicline—nicotine dependence	0.00323	0.00415	CcSEcCtD
Boceprevir—Visual impairment—Varenicline—nicotine dependence	0.00318	0.00408	CcSEcCtD
Boceprevir—Erythema multiforme—Varenicline—nicotine dependence	0.00312	0.004	CcSEcCtD
Boceprevir—Eye disorder—Varenicline—nicotine dependence	0.00308	0.00395	CcSEcCtD
Boceprevir—Tinnitus—Varenicline—nicotine dependence	0.00308	0.00394	CcSEcCtD
Boceprevir—Cardiac disorder—Varenicline—nicotine dependence	0.00306	0.00393	CcSEcCtD
Boceprevir—Angiopathy—Varenicline—nicotine dependence	0.00299	0.00384	CcSEcCtD
Boceprevir—Immune system disorder—Varenicline—nicotine dependence	0.00298	0.00382	CcSEcCtD
Boceprevir—Mediastinal disorder—Varenicline—nicotine dependence	0.00297	0.00381	CcSEcCtD
Boceprevir—Chills—Varenicline—nicotine dependence	0.00296	0.0038	CcSEcCtD
Boceprevir—Arrhythmia—Varenicline—nicotine dependence	0.00295	0.00378	CcSEcCtD
Boceprevir—Mental disorder—Varenicline—nicotine dependence	0.00289	0.00371	CcSEcCtD
Boceprevir—Malnutrition—Varenicline—nicotine dependence	0.00287	0.00368	CcSEcCtD
Boceprevir—Erythema—Varenicline—nicotine dependence	0.00287	0.00368	CcSEcCtD
Boceprevir—Flatulence—Varenicline—nicotine dependence	0.00283	0.00363	CcSEcCtD
Boceprevir—Dysgeusia—Varenicline—nicotine dependence	0.00281	0.00361	CcSEcCtD
Boceprevir—Back pain—Varenicline—nicotine dependence	0.00278	0.00356	CcSEcCtD
Boceprevir—Muscle spasms—Varenicline—nicotine dependence	0.00276	0.00354	CcSEcCtD
Boceprevir—Vision blurred—Varenicline—nicotine dependence	0.00271	0.00347	CcSEcCtD
Boceprevir—Ill-defined disorder—Varenicline—nicotine dependence	0.00266	0.00342	CcSEcCtD
Boceprevir—Anaemia—Varenicline—nicotine dependence	0.00265	0.0034	CcSEcCtD
Boceprevir—Agitation—Varenicline—nicotine dependence	0.00264	0.00338	CcSEcCtD
Boceprevir—Angioedema—Varenicline—nicotine dependence	0.00262	0.00337	CcSEcCtD
Boceprevir—Malaise—Varenicline—nicotine dependence	0.00259	0.00332	CcSEcCtD
Boceprevir—Vertigo—Varenicline—nicotine dependence	0.00258	0.00331	CcSEcCtD
Boceprevir—Syncope—Varenicline—nicotine dependence	0.00258	0.0033	CcSEcCtD
Boceprevir—ABCB1—midbrain—nicotine dependence	0.00254	0.0115	CbGeAlD
Boceprevir—Palpitations—Varenicline—nicotine dependence	0.00254	0.00325	CcSEcCtD
Boceprevir—Loss of consciousness—Varenicline—nicotine dependence	0.00252	0.00324	CcSEcCtD
Boceprevir—Cough—Varenicline—nicotine dependence	0.00251	0.00321	CcSEcCtD
Boceprevir—Hypertension—Varenicline—nicotine dependence	0.00248	0.00318	CcSEcCtD
Boceprevir—Arthralgia—Varenicline—nicotine dependence	0.00244	0.00314	CcSEcCtD
Boceprevir—Chest pain—Varenicline—nicotine dependence	0.00244	0.00314	CcSEcCtD
Boceprevir—Myalgia—Varenicline—nicotine dependence	0.00244	0.00314	CcSEcCtD
Boceprevir—Anxiety—Varenicline—nicotine dependence	0.00244	0.00312	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00243	0.00311	CcSEcCtD
Boceprevir—Discomfort—Varenicline—nicotine dependence	0.00242	0.0031	CcSEcCtD
Boceprevir—Dry mouth—Varenicline—nicotine dependence	0.00239	0.00307	CcSEcCtD
Boceprevir—Infection—Varenicline—nicotine dependence	0.00233	0.00299	CcSEcCtD
Boceprevir—Shock—Varenicline—nicotine dependence	0.00231	0.00296	CcSEcCtD
Boceprevir—Nervous system disorder—Varenicline—nicotine dependence	0.0023	0.00295	CcSEcCtD
Boceprevir—Thrombocytopenia—Varenicline—nicotine dependence	0.00229	0.00294	CcSEcCtD
Boceprevir—Tachycardia—Varenicline—nicotine dependence	0.00229	0.00293	CcSEcCtD
Boceprevir—Skin disorder—Varenicline—nicotine dependence	0.00228	0.00292	CcSEcCtD
Boceprevir—Hyperhidrosis—Varenicline—nicotine dependence	0.00227	0.00291	CcSEcCtD
Boceprevir—Hypotension—Varenicline—nicotine dependence	0.00219	0.00281	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00214	0.00274	CcSEcCtD
Boceprevir—Insomnia—Varenicline—nicotine dependence	0.00212	0.00272	CcSEcCtD
Boceprevir—Dyspnoea—Varenicline—nicotine dependence	0.00209	0.00268	CcSEcCtD
Boceprevir—Dyspepsia—Varenicline—nicotine dependence	0.00206	0.00265	CcSEcCtD
Boceprevir—Decreased appetite—Varenicline—nicotine dependence	0.00204	0.00261	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00202	0.0026	CcSEcCtD
Boceprevir—Fatigue—Varenicline—nicotine dependence	0.00202	0.00259	CcSEcCtD
Boceprevir—Constipation—Varenicline—nicotine dependence	0.002	0.00257	CcSEcCtD
Boceprevir—Pain—Varenicline—nicotine dependence	0.002	0.00257	CcSEcCtD
Boceprevir—Feeling abnormal—Varenicline—nicotine dependence	0.00193	0.00248	CcSEcCtD
Boceprevir—Gastrointestinal pain—Varenicline—nicotine dependence	0.00192	0.00246	CcSEcCtD
Boceprevir—Urticaria—Varenicline—nicotine dependence	0.00186	0.00239	CcSEcCtD
Boceprevir—Abdominal pain—Varenicline—nicotine dependence	0.00185	0.00238	CcSEcCtD
Boceprevir—Body temperature increased—Varenicline—nicotine dependence	0.00185	0.00238	CcSEcCtD
Boceprevir—Hypersensitivity—Varenicline—nicotine dependence	0.00173	0.00221	CcSEcCtD
Boceprevir—Asthenia—Varenicline—nicotine dependence	0.00168	0.00216	CcSEcCtD
Boceprevir—Pruritus—Varenicline—nicotine dependence	0.00166	0.00213	CcSEcCtD
Boceprevir—Diarrhoea—Varenicline—nicotine dependence	0.0016	0.00206	CcSEcCtD
Boceprevir—ABCB1—brain—nicotine dependence	0.0016	0.00725	CbGeAlD
Boceprevir—Dizziness—Varenicline—nicotine dependence	0.00155	0.00199	CcSEcCtD
Boceprevir—Vomiting—Varenicline—nicotine dependence	0.00149	0.00191	CcSEcCtD
Boceprevir—Rash—Varenicline—nicotine dependence	0.00148	0.0019	CcSEcCtD
Boceprevir—Dermatitis—Varenicline—nicotine dependence	0.00148	0.00189	CcSEcCtD
Boceprevir—Headache—Varenicline—nicotine dependence	0.00147	0.00188	CcSEcCtD
Boceprevir—Nausea—Varenicline—nicotine dependence	0.00139	0.00179	CcSEcCtD
